| |
OR (IC95%)
|
P
|
|---|
|
Age > 60 years
|
0.86 (0.40–1.83)
|
0.700
|
|
Length of stay > 7 days
|
6.52 (4.84–8.52)
|
< 0.001
|
|
APACHE II > 20
|
1.98 (0.89–2.62)
|
0.092
|
|
Hematologic disease
|
0.84 (0.17–3.97)
|
0.825
|
|
Solid Organ Transplantation
|
1.59 (0.31–8.26)
|
0.580
|
|
Origin
|
1.38 (1.21–1.57)
|
0.168
|
|
Immunosuppression
|
1.27 (0.47–3.40)
|
0.641
|
|
Diabetes
|
0.63 (0.26–1.56)
|
0.320
|
|
Cirrhosis
|
1.92 (0.36–10.37)
|
0.477
|
|
1COPD
|
0.89 (0.82–1.74)
|
0.380
|
|
Mechanical ventilation
|
1.34 (0.61–2.95)
|
0.465
|
|
Renal replacement therapy
|
1.66 (0.91–2.14)
|
0.134
|
|
Parenteral Nutrition
|
2.18 (1.01–4.69)
|
0.045
|
|
Respiratory infection
|
2.05 (0.93–4.53)
|
0.074
|
|
Sepsis/Septic Shock
|
0.39 (0.04–2.69)
|
0.306
|
|
Antibiotics > 48 h
|
5.60 (3.92–7.98)
|
< 0.001
|
|
Carbapenem
|
1.33 (0.93–1.89)
|
0.108
|
|
Quinolones
|
1.21 (0.85–1.70)
|
0.297
|
|
2IBL
|
3.75 (2.83–4.97)
|
< 0.001
|
|
Cephalosporin
|
1.87 (1.38–2.53)
|
< 0.001
|
|
Amynoglycosides
|
3.78 (2.67–5.37)
|
< 0.001
|
|
Linezolid
|
3.02 (1.21–4.17)
|
< 0.001
|
|
3SDD
|
0.45 (0.05–3.64)
|
0.454
|
- 1COPD: Chronic obstructive pulmonary disease; 2BLI: b-lactamase inhibitors; 3SDD: Selective digestive decontamination
